To Get Help Now
Click Here
 
Today's Date:

Merck Wins Fourth Fosamax Trial

AddThis Social Bookmark Button

Merck has reported its fourth Fosamax win in the five lawsuits that have gone to trial thus far. More than 1650 lawsuits have been filed and are pending in federal and state courts. This last case was heard before a jury in New York, who ruled against a Florida woman who said she suffered jaw problems after taking Fosamax.

Fosamax is a bisphosphonates drug used to treat the chronic condition osteoporosis, which causes bones to weaken and fracture.

So far, Merck has lost only the second case heard by a jury. In that case, the jury awarded the plaintiff $8 million. The award was later reduced to $1.5 million. Merck is appealing that verdict.

The Journal of Dental Research published a report in February that found that bisphosphonates drugs like Fosamax could cause osteonecrosis of the jaw. Osteonecrosis, or bone death, is caused when blood flow to a bone is decreased for an extended period. Merck has reported that no cases of osteonecrosis of the jaw in any Fosamax clinical trials, Business Week reported.

breakinglawsuitnews.com disclaimer: This article: Merck Wins Fourth Fosamax Trial was posted on Wednesday, October 5th, 2011 at 7:38 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.